Bold Capital Select
Bold Capital Select is a venture capital fund managed by Bold Capital Partners, which was founded in 2015 and is based in Santa Monica, California. The fund focuses on early-stage investments primarily in technology companies across various sectors, including communications, education, healthcare, artificial intelligence, and digital health, among others. With a commitment to fostering innovation, Bold Capital Select aims to support companies that are poised for exponential transformation within their respective industries. The firm's investment strategy reflects a broad interest in advanced technologies and their applications, positioning it to capitalize on emerging trends in the market.
Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.
Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.
Viome, Inc. is a biotechnology company based in Bellevue, Washington, that specializes in wellness monitoring through at-home clinical-grade testing kits. Founded in 2016, the company combines analyses of blood, urine, saliva, and stool samples to create detailed profiles of an individual's biochemistry and gut microbiome. Utilizing proprietary RNA sequencing technology, Viome assesses the microbial communities in the digestive system and provides users with personalized insights related to their health. The findings are integrated into a smartphone application that offers tailored recommendations for diet and lifestyle adjustments aimed at preventing and reversing chronic diseases. Viome markets its products through various distributors and online platforms, operating as a subsidiary of BlueDot LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.